MT
LIVE

Serial Number

99057333

Owner

CPC Scientific Inc.

Attorney

Candice M. Kwok

Filing Date

Feb 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MT Trademark

Serial Number: 99057333

MT is a trademark filed by CPC Scientific Inc. on February 26, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CPC Scientific Inc. (4 trademarks)

1900 McCarthy Blvd, Suite 204
Milpitas, CA 95035

Entity Type: 03

Trademark Details

Filing Date

February 26, 2025

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Scientific and chemical research; chemical engineering; product research and development for the pharmaceutical industry; research and development services in the field of chemistry, peptides, proteins, and oligonucleotides; research and development services in the field of pharmaceutical preparations and biochemistry, cosmetics and diagnostic preparations; research in the fields of chemistry and biology; development of production methods for peptides, proteins, oligonucleotides and cosmetics; research in the field of recombinant DNA technology; scientific analysis, namely, analytical method development for peptides, proteins, oligonucleotides, pharmaceuticals and cosmetics; scientific laboratory services; chemical analysis; chemical, biochemical, biological and bacteriological research and analysis; analysis in the form of research in the field of molecular biology; conduct scientific feasibility studies; provide scientific research report preparation; quality control for others; product testing; scientific and technology consultancy in the fields of material testing, biochemistry, and chemistry industries, and laboratory testing research

Financial consultancy in the fields of material testing, biochemistry, chemistry and science industries, and laboratory testing research

Chemicals, chemical preparations and chemical reagents for use in industry and science; chemical compounds, namely, peptides, proteins, and oligonucleotides for use in industry and science; chemical compounds, namely, oligopeptides for industrial use; chemical compounds, namely, proteins for use in manufacture; amino acids for industrial and scientific use; peptide substrates for scientific use; chemical preparations, peptides, oligonucleotides being chemical compounds and proteins for use in the manufacture of cosmetics; chemical preparations for use in the production of medicines and in the manufacture of pharmaceuticals; chemical compounds, namely, peptides, proteins, and oligonucleotides for use in the manufacture of pharmaceuticals; chemicals for use in biotechnological manufacturing processes and in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs, anti-diabetes drugs, drugs against metabolic diseases, drugs for wound healing, drugs against genetic diseases, and drugs against neurological diseases; diagnostic preparations and diagnostic reagents for scientific or research use; biochemical preparations for scientific use

Business consultancy in the fields of material testing, biochemistry, chemistry and science industries, and laboratory testing research

Chemical reagents, diagnostic preparations and diagnostic test reagents for medical and veterinary use; peptides, oligonucleotides and amino acids for medical, pharmaceutical and veterinary use, in treating infectious diseases, metabolic diseases and cancer; protein arrays for diagnostic use; biological and pharmaceutical preparations, peptides, proteins, and oligonucleotides for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; pharmaceutical preparations for use against metabolic, genetic, neurological diseases and for wound healing; anti-bacterial preparations for medical purposes; anti-cancer and anti-diabetic preparations; antitumor drugs; biopharmaceutical anti-tumor medicines; biopharmaceuticals for cancer treatments; chemotherapeutics; cosmeceuticals being pharmaceutical products for therapeutic and medical use in treating infectious diseases, metabolic diseases and cancer; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic preparations adapted for medical and veterinary uses; drug delivery agents in the form of tablet coatings that facilitate pharmaceutical preparation delivery; in vitro diagnostic preparations for medical use

Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacturing of peptides; custom manufacturing of proteins; custom manufacturing of oligonucleotides; processing of chemicals; processing of chemical reagents; processing of peptides; processing of proteins; processing of oligonucleotides; processing of medicinal materials; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 31, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 31, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 26, 2025 MAFR
NEW APPLICATION ENTERED
Feb 26, 2025 NWAP